VOGT FREDERICK G (Interim CEO & General Counsel) exercised options at IOVANCE BIOTHERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 6/3/2026ACC: 0001104659-26-070155
DirectorOfficer· Interim CEO & General Counsel
Since Mar 2026
-17.70K
Net shares
Net seller
$70.1K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
41.67K acquired · 59.37K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+41.67K
Price / share
—
Trade value
—
% of position
7.9%
6/1/2026
529.54K→571.21K
Common Stock
Direct
Shares
−17.70K
Price / share
$3.96
Trade value
$70.10K
% of position
3.1%
6/1/2026
571.21K→553.50K
Total
Net shares
+23.97K
Net value
-$70.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | M · Option Exercise | +41.67K | — | — | 7.9% | 529.54K | 571.21K |
| Common Stock Direct | 6/1/2026 | F · Tax Withholding | −17.70K | $3.96 | $70.10K | 3.1% | 571.21K | 553.50K |
| Total | +23.97K | -$70.10K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common stock
41.67K shares
Shares
−41.67K
Strike price
Held after
125.01K
Exercisable
—
6/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common stock41.67K shares | 6/1/2026 | M · Option Exercise | −41.67K | — | 125.01K |